HMGA2 and ovarian cancer: Moreover, miR-219-5p inhibits Wnt/β-catenin signaling and autophagy in ovarian cancer cells by targeting HMGA2 (105) and reduces cisplatin resistance by suppressing Wnt/β-catenin signaling and autophagy through HMGA2 targeting in these cells (107).